These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34157093)

  • 1. Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study.
    Horwitz ME; Stiff PJ; Cutler C; Brunstein C; Hanna R; Maziarz RT; Rezvani AR; Karris NA; McGuirk J; Valcarcel D; Schiller GJ; Lindemans CA; Hwang WYK; Koh LP; Keating A; Khaled Y; Hamerschlak N; Frankfurt O; Peled T; Segalovich I; Blackwell B; Wease S; Freedman LS; Galamidi-Cohen E; Sanz G
    Blood; 2021 Oct; 138(16):1429-1440. PubMed ID: 34157093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospitalization and Healthcare Resource Utilization of Omidubicel-Onlv versus Umbilical Cord Blood Transplantation for Hematologic Malignancies: Secondary Analysis from a Pivotal Phase 3 Clinical Trial.
    Majhail NS; Miller B; Dean R; Manghani R; Shin H; Sivaraman S; Maziarz RT
    Transplant Cell Ther; 2023 Dec; 29(12):749.e1-749.e5. PubMed ID: 37703995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
    Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
    Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide.
    Horwitz ME; Wease S; Blackwell B; Valcarcel D; Frassoni F; Boelens JJ; Nierkens S; Jagasia M; Wagner JE; Kuball J; Koh LP; Majhail NS; Stiff PJ; Hanna R; Hwang WYK; Kurtzberg J; Cilloni D; Freedman LS; Montesinos P; Sanz G
    J Clin Oncol; 2019 Feb; 37(5):367-374. PubMed ID: 30523748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic stem cell transplantation with omidubicel in sickle cell disease.
    Parikh S; Brochstein JA; Galamidi E; Schwarzbach A; Kurtzberg J
    Blood Adv; 2021 Feb; 5(3):843-852. PubMed ID: 33560399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood.
    Lin C; Sajeev G; Stiff PJ; Brunstein CG; Cutler C; Sanz G; Lindemans CA; Rezvani AR; Hanna R; Koh LP; Maziarz RT; Hwang WYK; Song Y; Liu Q; Manghani R; Sivaraman S; Signorovitch J; Horwitz ME; Sung AD
    Transplant Cell Ther; 2023 Jan; 29(1):52.e1-52.e9. PubMed ID: 36179986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of intensified myeloablative conditioning regime without antithymocytic globulin (ATG) with myeloablative conditioning regime for single-unit unrelated umbilical cord blood transplantation in hematological malignancies].
    Sun ZM; Liu HL; Wu Y; Geng LQ; Zheng CC; Tang BL; Zhu XY; Tong J; Wang XB; Ding KY; Wan X; Zhang L; Yao W; Zhang XH; Han YS; Yang HZ; Liu X; Zhu WW; Wu JS; Wang ZY
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2214-9. PubMed ID: 27480651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies.
    Sanz J; Montoro J; Solano C; Valcárcel D; Sampol A; Ferrá C; Parody R; Lorenzo I; Montesinos P; Ortí G; Hernández-Boluda JC; Balaguer-Roselló A; Guerreiro M; Carretero C; Sanz GF; Sanz MA; Piñana JL
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):358-366. PubMed ID: 31655119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy.
    Szabolcs P; Mazor RD; Yackoubov D; Levy S; Stiff P; Rezvani A; Hanna R; Wagner J; Keating A; Lindemans CA; Karras N; McGuirk J; Hamerschlak N; López-Torija I; Sanz G; Valcarcel D; Horwitz ME
    Transplant Cell Ther; 2023 Aug; 29(8):517.e1-517.e12. PubMed ID: 37120136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of calcineurin inhibitors in combination with conventional methotrexate, reduced methotrexate, or mycophenolate mofetil for prophylaxis of graft-versus-host disease after umbilical cord blood transplantation.
    Yoshida S; Ohno Y; Nagafuji K; Yoshimoto G; Sugio T; Kamimura T; Ohta T; Takase K; Henzan H; Muta T; Iwasaki H; Ogawa R; Eto T; Akashi K; Miyamoto T
    Ann Hematol; 2019 Nov; 98(11):2579-2591. PubMed ID: 31628517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.
    Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1722-1728. PubMed ID: 28647558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment.
    Hexner EO; Luger SM; Reshef R; Jeschke GR; Mangan JK; Frey NV; Frank DM; Richman LP; Vonderheide RH; Aqui NA; Rosenbach M; Zhang Y; Chew A; Loren AW; Stadtmauer EA; Levine BL; June CH; Emerson SG; Porter DL
    Am J Hematol; 2016 May; 91(5):453-60. PubMed ID: 26858124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
    van Besien K; Hari P; Zhang MJ; Liu HT; Stock W; Godley L; Odenike O; Larson R; Bishop M; Wickrema A; Gergis U; Mayer S; Shore T; Tsai S; Rhodes J; Cushing MM; Korman S; Artz A
    Haematologica; 2016 May; 101(5):634-43. PubMed ID: 26869630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.
    Chen YH; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang FR; Wang JZ; Wang Y; Huang XJ; Liu KY
    Chin Med J (Engl); 2013 Jul; 126(13):2499-503. PubMed ID: 23823825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation.
    Sanz J; Picardi A; Hernández Boluda JC; Martín C; Ferrá C; Nozzoli C; Gonzalez-Vicent M; Rambaldi A; Valcarcel D; Verdeguer A; Serrano D; de Heredia CD; Pascual MJ; de Paz R; Montesinos P; Bartolozzi B; Algarotti A; Sanz MA; Arcese W; Sanz GF;
    Biol Blood Marrow Transplant; 2013 Sep; 19(9):1387-92. PubMed ID: 23850652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients.
    De Sa H; Maziarz RT; Gandhi AP
    Expert Opin Biol Ther; 2024 Mar; 24(3):139-146. PubMed ID: 38481366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment.
    Horwitz ME; Chao NJ; Rizzieri DA; Long GD; Sullivan KM; Gasparetto C; Chute JP; Morris A; McDonald C; Waters-Pick B; Stiff P; Wease S; Peled A; Snyder D; Cohen EG; Shoham H; Landau E; Friend E; Peleg I; Aschengrau D; Yackoubov D; Kurtzberg J; Peled T
    J Clin Invest; 2014 Jul; 124(7):3121-8. PubMed ID: 24911148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The curative efficacy of unrelated umbilical cord blood stem cells transplantation in intensified myeloablative conditioned patients with acute lymphoblastic leukemia].
    Tang B; Zheng C; Liu H; Zhu X; Geng L; Wang X; Ding K; Yao W; Tong J; Song K; Zhang L; Qiang P; Zhang X; Sun Z
    Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):191-5. PubMed ID: 26926370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of unrelated umbilical cord blood transplantation for 25 patients with hematological diseases].
    Chang HR; Cheng Z; Chen GH; Sun AN; Qiao M; Ma X; Wang Y; Chen F; Jin HY; Lu Y; Zhang JQ; Fu CC; Jin ZM; Tang XW; Han Y; Qiu HY; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):767-73. PubMed ID: 24989292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-unit versus two-unit cord-blood transplantation for hematologic cancers.
    Wagner JE; Eapen M; Carter S; Wang Y; Schultz KR; Wall DA; Bunin N; Delaney C; Haut P; Margolis D; Peres E; Verneris MR; Walters M; Horowitz MM; Kurtzberg J;
    N Engl J Med; 2014 Oct; 371(18):1685-94. PubMed ID: 25354103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.